Nothing Special   »   [go: up one dir, main page]

DK1329456T3 - Glucopyranosyloxybenzylbenzenderivater og medicinske sammensætninger indeholdende samme - Google Patents

Glucopyranosyloxybenzylbenzenderivater og medicinske sammensætninger indeholdende samme

Info

Publication number
DK1329456T3
DK1329456T3 DK01970186T DK01970186T DK1329456T3 DK 1329456 T3 DK1329456 T3 DK 1329456T3 DK 01970186 T DK01970186 T DK 01970186T DK 01970186 T DK01970186 T DK 01970186T DK 1329456 T3 DK1329456 T3 DK 1329456T3
Authority
DK
Denmark
Prior art keywords
same
compositions containing
medical compositions
glucopyranosyloxybenzylbenzene derivatives
glucopyranosyloxybenzylbenzene
Prior art date
Application number
DK01970186T
Other languages
Danish (da)
English (en)
Inventor
Nobuhiko Fushimi
Toshihiro Nishimura
Masayuki Isaji
Hideki Fujikura
Kazuya Tatani
Original Assignee
Kissei Pharmaceutical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kissei Pharmaceutical filed Critical Kissei Pharmaceutical
Application granted granted Critical
Publication of DK1329456T3 publication Critical patent/DK1329456T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/203—Monocyclic carbocyclic rings other than cyclohexane rings; Bicyclic carbocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Diabetes (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Obesity (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
DK01970186T 2000-09-29 2001-09-21 Glucopyranosyloxybenzylbenzenderivater og medicinske sammensætninger indeholdende samme DK1329456T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2000301523 2000-09-29

Publications (1)

Publication Number Publication Date
DK1329456T3 true DK1329456T3 (da) 2006-12-04

Family

ID=18783054

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01970186T DK1329456T3 (da) 2000-09-29 2001-09-21 Glucopyranosyloxybenzylbenzenderivater og medicinske sammensætninger indeholdende samme

Country Status (33)

Country Link
US (2) US6872706B2 (ko)
EP (1) EP1329456B1 (ko)
JP (1) JP3798375B2 (ko)
KR (1) KR100647204B1 (ko)
CN (1) CN1293087C (ko)
AR (1) AR030816A1 (ko)
AT (1) ATE335753T1 (ko)
AU (2) AU9025701A (ko)
BG (1) BG66015B1 (ko)
BR (1) BR0114310A (ko)
CA (1) CA2423568C (ko)
CY (1) CY1106076T1 (ko)
CZ (1) CZ303544B6 (ko)
DE (1) DE60122193T2 (ko)
DK (1) DK1329456T3 (ko)
EA (1) EA005994B1 (ko)
ES (1) ES2269456T3 (ko)
HK (1) HK1061037A1 (ko)
HU (1) HUP0301178A3 (ko)
IL (2) IL155071A0 (ko)
MX (1) MXPA03002779A (ko)
MY (1) MY129023A (ko)
NO (1) NO327182B1 (ko)
NZ (1) NZ524917A (ko)
PE (1) PE20020476A1 (ko)
PL (1) PL205607B1 (ko)
PT (1) PT1329456E (ko)
SI (1) SI1329456T1 (ko)
SK (1) SK287811B6 (ko)
TW (1) TWI284641B (ko)
UA (1) UA73606C2 (ko)
WO (1) WO2002028872A1 (ko)
ZA (1) ZA200302283B (ko)

Families Citing this family (65)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1020944C (zh) 1990-01-30 1993-05-26 阿图尔-费希尔股份公司费希尔厂 紧固件
US6872706B2 (en) 2000-09-29 2005-03-29 Kissei Pharmaceutical Co., Ltd. Glucopyranosyloxybenzylbenzene derivatives and medicinal compositions containing the same
EP1344780A4 (en) * 2000-11-30 2004-01-28 Kissei Pharmaceutical GLUCOPYRANOSYLOXYBENZYLBENZOLE DERIVATIVES, MEDICAL COMPOSITIONS CONTAINING THESE COMPOUNDS AND INTERMEDIATE PRODUCTS FOR THEIR PREPARATION
TWI255817B (en) 2001-02-14 2006-06-01 Kissei Pharmaceutical Glucopyranosyloxybenzylbenzene derivatives and medicinal use thereof
NZ535230A (en) * 2002-03-22 2006-10-27 Kissei Pharmaceutical Crystals of glucopyranosyloxybenzyl benzene derivative
CA2493491A1 (en) * 2002-08-09 2004-02-19 Taisho Pharmaceutical Co., Ltd. Process for selective production of aryl 5-thio-.beta.-d-aldohexopyranosides
JP4651934B2 (ja) * 2002-12-04 2011-03-16 キッセイ薬品工業株式会社 ベンジルフェノール誘導体、それを含有する医薬組成物およびその医薬用途
CA2507665A1 (en) * 2002-12-04 2004-06-17 Kissei Pharmaceutical Co., Ltd. Preventive or remedy for diseases caused by hyperglycemia
DE10258007B4 (de) 2002-12-12 2006-02-09 Sanofi-Aventis Deutschland Gmbh Aromatische Fluorglycosidderivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zur Herstellung dieser Arzneimittel
DE10258008B4 (de) * 2002-12-12 2006-02-02 Sanofi-Aventis Deutschland Gmbh Heterocyclische Fluorglycosidderivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zur Herstellung dieser Arzneimittel
UA86042C2 (en) * 2003-08-01 2009-03-25 Янссен Фармацевтика Н.В. Substituted indazole-o-glucosides
NZ550464A (en) * 2004-03-16 2010-10-29 Boehringer Ingelheim Int Glucopyranosyl-substituted benzol derivatives, drugs containing said compounds, the use thereof and method for the production thereof
CA2560005A1 (en) * 2004-03-31 2005-10-13 Kissei Pharmaceutical Co., Ltd. Phenol derivative, medicinal composition containing the same, and medicinal use thereof
JP5010918B2 (ja) * 2004-07-21 2012-08-29 キッセイ薬品工業株式会社 肝臓脂肪の異常蓄積に起因する疾患の進展抑制剤
TW200606129A (en) 2004-07-26 2006-02-16 Chugai Pharmaceutical Co Ltd Novel cyclohexane derivative, its prodrug, its salt and diabetic therapeutic agent containing the same
ES2314743T3 (es) * 2004-12-16 2009-03-16 Boehringer Ingelheim International Gmbh Derivados de benceno sustituidos con glucopiranosilo, medicamentos que contienen a este tipo de compuestos, su uso y procedimiento para su fabricacion.
TW200637869A (en) 2005-01-28 2006-11-01 Chugai Pharmaceutical Co Ltd The spiroketal derivatives and the use as therapeutical agent for diabetes of the same
JP5073948B2 (ja) * 2005-01-31 2012-11-14 田辺三菱製薬株式会社 医薬組成物
DE602006009772D1 (de) * 2005-02-23 2009-11-26 Boehringer Ingelheim Int Glucopyranosylsubstituierte ((hetero)arylethynyl-benzyl)-benzenderivative und deren verwendung als inhibitoren des natriumabhängigen glucose-cotransporters typ 2 (sglt2)
JP5238492B2 (ja) * 2005-04-15 2013-07-17 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Ｓｇｌｔインヒビターとしてのグルコピラノシル置換（ヘテロアリールオキシ−ベンジル）−ベンゼン誘導体
US7723309B2 (en) * 2005-05-03 2010-05-25 Boehringer Ingelheim International Gmbh Crystalline forms of 1-chloro-4-(β-D-glucopyranos-1-yl)-2-[4-((R)-tetrahydrofuran-3-yloxy)-benzyl]-benzene, a method for its preparation and the use thereof for preparing medicaments
UA91546C2 (uk) 2005-05-03 2010-08-10 Бьорінгер Інгельхайм Інтернаціональ Гмбх КРИСТАЛІЧНА ФОРМА 1-ХЛОР-4-(β-D-ГЛЮКОПІРАНОЗ-1-ИЛ)-2-[4-((S)-ТЕТРАГІДРОФУРАН-3-ІЛОКСИ)-БЕНЗИЛ]-БЕНЗОЛУ, СПОСІБ ЇЇ ОДЕРЖАННЯ ТА ЇЇ ЗАСТОСУВАННЯ ПРИ ПРИГОТУВАННІ ЛІКАРСЬКИХ ЗАСОБІВ
US7772191B2 (en) * 2005-05-10 2010-08-10 Boehringer Ingelheim International Gmbh Processes for preparing of glucopyranosyl-substituted benzyl-benzene derivatives and intermediates therein
JP5128474B2 (ja) * 2005-07-27 2013-01-23 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング グルコピラノシル−置換（（ヘテロ）シクロアルキルエチニル−ベンジル）−ベンゼン誘導体、該化合物を含有する薬剤、それらの使用及びそれらの製造方法
WO2007025943A2 (en) * 2005-08-30 2007-03-08 Boehringer Ingelheim International Gmbh Glucopyranosyl-substituted benzyl-benzene derivatives, medicaments containing such compounds, their use and process for their manufacture
EP1926720B1 (en) * 2005-09-08 2010-12-15 Boehringer Ingelheim International GmbH CRYSTALLINE FORMS OF 1-CHLORO-4-(ß-D-GLUCOPYRANOS-1-YL)-2-(4-ETHYNYL-BENZYL)-BENZENE, METHODS FOR ITS PREPARATION AND THE USE THEREOF FOR PREPARING MEDICAMENTS
AR056195A1 (es) * 2005-09-15 2007-09-26 Boehringer Ingelheim Int Procedimientos para preparar derivados de (etinil-bencil)-benceno sustituidos de glucopiranosilo y compuestos intermedios de los mismos
EA200801773A1 (ru) * 2006-02-15 2009-02-27 Бёрингер Ингельхайм Интернациональ Гмбх Глюкопиранозилзамещенные производные бензонитрила, фармацевтические композиции, содержащие такие соединения, их применение и способ их получения
PE20080697A1 (es) 2006-05-03 2008-08-05 Boehringer Ingelheim Int Derivados de benzonitrilo sustituidos con glucopiranosilo, composiciones farmaceuticas que contienen compuestos de este tipo, su uso y procedimiento para su fabricacion
PE20110235A1 (es) 2006-05-04 2011-04-14 Boehringer Ingelheim Int Combinaciones farmaceuticas que comprenden linagliptina y metmorfina
DE102006028862A1 (de) 2006-06-23 2007-12-27 Merck Patent Gmbh 3-Amino-imidazo[1,2-a]pyridinderivate
TW200817424A (en) 2006-08-04 2008-04-16 Daiichi Sankyo Co Ltd Benzylphenyl glucopyranoside derivatives
US20080109178A1 (en) * 2006-11-03 2008-05-08 Nikon Corporation Method and system for predicting and correcting signal fluctuations of an interferometric measuring apparatus
JP5330260B2 (ja) 2006-12-06 2013-10-30 スミスクライン ビーチャム コーポレーション 二環式化合物ならびに抗糖尿病薬としての使用
DE102007008420A1 (de) 2007-02-21 2008-08-28 Merck Patent Gmbh Benzimidazolderivate
PE20090938A1 (es) * 2007-08-16 2009-08-08 Boehringer Ingelheim Int Composicion farmaceutica que comprende un derivado de benceno sustituido con glucopiranosilo
DE102007048716A1 (de) 2007-10-11 2009-04-23 Merck Patent Gmbh Imidazo[1,2-a]pyrimidinderivate
CL2008003653A1 (es) 2008-01-17 2010-03-05 Mitsubishi Tanabe Pharma Corp Uso de un inhibidor de sglt derivado de glucopiranosilo y un inhibidor de dppiv seleccionado para tratar la diabetes; y composicion farmaceutica.
WO2009096503A1 (ja) * 2008-01-31 2009-08-06 Daiichi Sankyo Company, Limited ベンジルフェニルグルコピラノシド誘導体
DE102008017590A1 (de) 2008-04-07 2009-10-08 Merck Patent Gmbh Glucopyranosidderivate
RU2509773C2 (ru) 2008-07-15 2014-03-20 Теракос, Инк. Дейтерированные бензилбензольные производные и способы применения
KR101446454B1 (ko) * 2008-08-28 2014-10-06 화이자 인코포레이티드 다이옥사-바이사이클로[3.2.1]옥테인-2,3,4-트라이올 유도체
MA33046B1 (fr) 2009-02-13 2012-02-01 Boehringer Ingelheim Int Composition pharmaceutique contenant un inhibiteur sglt-2, un inhibiteur dpp- iv et facultativemenet un autre agent antidiabetique et ses utilisations
PL2395968T3 (pl) * 2009-02-13 2024-06-24 Boehringer Ingelheim International Gmbh Kompozycja farmaceutyczna zawierająca pochodne glukopiranozylodifenylometanowe, zawierająca ją farmaceutyczna postać dawkowania, proces ich wytwarzania oraz ich zastosowania dla poprawy kontroli glikemii u pacjenta
ES2546762T3 (es) 2009-09-30 2015-09-28 Boehringer Ingelheim International Gmbh Procedimientos para preparar derivados de bencil-benceno sustituidos con glucopiranosilo
NZ598318A (en) * 2009-09-30 2014-02-28 Boehringer Ingelheim Int Method for the preparation of a crystalline form of 1-chloro-4- (beta-d-glucopyranos-1-yl)-2-(4-((s)-tetrahydrofuran-3-yloxy)benzyl)benzene
US10610489B2 (en) * 2009-10-02 2020-04-07 Boehringer Ingelheim International Gmbh Pharmaceutical composition, pharmaceutical dosage form, process for their preparation, methods for treating and uses thereof
EP2491050A2 (en) 2009-10-20 2012-08-29 Novartis AG Glycoside derivative and uses thereof
US8163704B2 (en) 2009-10-20 2012-04-24 Novartis Ag Glycoside derivatives and uses thereof
NZ599945A (en) 2009-11-02 2014-05-30 Pfizer Dioxa-bicyclo[3.2.1]octane-2,3,4-triol derivatives
AR079438A1 (es) 2009-12-09 2012-01-25 Panacea Biotec Ltd Derivados de azucar, composiciones farmaceuticas y sus usos
WO2011107494A1 (de) 2010-03-03 2011-09-09 Sanofi Neue aromatische glykosidderivate, diese verbindungen enthaltende arzneimittel und deren verwendung
WO2012025857A1 (en) 2010-08-23 2012-03-01 Hetero Research Foundation Cycloalkyl methoxybenzyl phenyl pyran derivatives as sodium dependent glucose co transporter (sglt2) inhibitors
AR085689A1 (es) 2011-03-07 2013-10-23 Boehringer Ingelheim Int Composiciones farmaceuticas de metformina, linagliptina y un inhibidor de sglt-2
KR20140019834A (ko) 2011-04-14 2014-02-17 노파르티스 아게 글리코시드 유도체 및 그의 용도
US8614195B2 (en) 2011-04-14 2013-12-24 Novartis Ag Glycoside derivatives and uses thereof
US9555001B2 (en) 2012-03-07 2017-01-31 Boehringer Ingelheim International Gmbh Pharmaceutical composition and uses thereof
US9192617B2 (en) 2012-03-20 2015-11-24 Boehringer Ingelheim International Gmbh Pharmaceutical composition, methods for treating and uses thereof
EP2774619B1 (de) 2013-03-04 2016-05-18 BioActive Food GmbH Zusammensetzung zur Behandlung von hyperglykämischen Erkrankungen
WO2014159452A1 (en) 2013-03-14 2014-10-02 Mars, Incorporated Flavor composition containing hmg glucosides
US20140303097A1 (en) 2013-04-05 2014-10-09 Boehringer Ingelheim International Gmbh Pharmaceutical composition, methods for treating and uses thereof
US11813275B2 (en) 2013-04-05 2023-11-14 Boehringer Ingelheim International Gmbh Pharmaceutical composition, methods for treating and uses thereof
US20140303098A1 (en) 2013-04-05 2014-10-09 Boehringer Ingelheim International Gmbh Pharmaceutical composition, methods for treating and uses thereof
HRP20220365T1 (hr) 2013-04-18 2022-05-13 Boehringer Ingelheim International Gmbh Farmaceutski pripravak, postupci za liječenje i njegove uporabe
EP2944311A1 (de) 2014-05-16 2015-11-18 BioActive Food GmbH Kombination von biologisch aktiven Substanzen zur Behandlung von hyperglykämischen Erkrankungen

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2549476B1 (fr) * 1983-07-20 1986-04-25 Rech Ind Benzyl-phenyl-osides, procede de preparation et utilisation en therapeutique
CA2102591C (en) 1992-11-12 2000-12-26 Kenji Tsujihara Hypoglycemic agent
US5731292A (en) * 1992-11-12 1998-03-24 Tanabe Seiyaku Co., Ltd. Dihydrochalcone derivatives which are hypoglycemic agents
AU2001241146B8 (en) * 2000-03-17 2006-07-27 Kissei Pharmaceutical Co., Ltd. Glucopyranosyloxy benzylbenzene derivatives, medicinal compositions containing the same and intermediates for the preparation of the derivatives
US6683056B2 (en) * 2000-03-30 2004-01-27 Bristol-Myers Squibb Company O-aryl glucoside SGLT2 inhibitors and method
US6872706B2 (en) 2000-09-29 2005-03-29 Kissei Pharmaceutical Co., Ltd. Glucopyranosyloxybenzylbenzene derivatives and medicinal compositions containing the same

Also Published As

Publication number Publication date
JP3798375B2 (ja) 2006-07-19
ES2269456T3 (es) 2007-04-01
NO20031407L (no) 2003-04-30
PL205607B1 (pl) 2010-05-31
NZ524917A (en) 2005-01-28
UA73606C2 (en) 2005-08-15
NO327182B1 (no) 2009-05-04
PL362177A1 (en) 2004-10-18
CZ303544B6 (cs) 2012-11-28
ATE335753T1 (de) 2006-09-15
BR0114310A (pt) 2003-10-14
US6872706B2 (en) 2005-03-29
HUP0301178A3 (en) 2009-08-28
AU2001290257B2 (en) 2007-08-30
PE20020476A1 (es) 2002-07-04
CY1106076T1 (el) 2011-06-08
SK3342003A3 (en) 2003-08-05
DE60122193T2 (de) 2007-07-05
JPWO2002028872A1 (ja) 2004-02-12
KR100647204B1 (ko) 2006-11-17
CN1466590A (zh) 2004-01-07
MXPA03002779A (es) 2004-05-04
EP1329456A1 (en) 2003-07-23
MY129023A (en) 2007-03-30
HK1061037A1 (en) 2004-09-03
SK287811B6 (sk) 2011-10-04
EP1329456A4 (en) 2005-03-30
KR20030036867A (ko) 2003-05-09
EA005994B1 (ru) 2005-08-25
ZA200302283B (en) 2005-05-27
AR030816A1 (es) 2003-09-03
TWI284641B (en) 2007-08-01
EP1329456B1 (en) 2006-08-09
BG66015B1 (bg) 2010-10-29
DE60122193D1 (de) 2006-09-21
SI1329456T1 (sl) 2006-12-31
CA2423568A1 (en) 2002-04-11
US20050065098A1 (en) 2005-03-24
EA200300316A1 (ru) 2003-08-28
CA2423568C (en) 2011-03-15
HUP0301178A2 (hu) 2003-11-28
WO2002028872A1 (fr) 2002-04-11
PT1329456E (pt) 2006-12-29
BG107674A (bg) 2004-01-30
IL155071A (en) 2010-04-15
NO20031407D0 (no) 2003-03-27
AU9025701A (en) 2002-04-15
US20040018998A1 (en) 2004-01-29
CN1293087C (zh) 2007-01-03
IL155071A0 (en) 2003-10-31

Similar Documents

Publication Publication Date Title
DK1329456T3 (da) Glucopyranosyloxybenzylbenzenderivater og medicinske sammensætninger indeholdende samme
DK1353919T3 (da) Hidtil ukendte quinuclidinderivater og medicinale sammensætninger indeholdende samme
DK1242095T3 (da) Antimikrobielle sammensætninger og fremgangsmåder til anvendelse deraf
IL152451A0 (en) 2-chloro-2-nitrophenylcarboxamide derivatives and pharmaceutical compositions containing the same
IL153123A0 (en) N-ureidoheterocycloalkyl-piperidine derivatives and pharmaceutical compositions containing the same
IL158041A0 (en) Benzimidazole derivatives and pharmaceutical compositions containing the same
IL161616A0 (en) Indazolypyrrolotriazine derivatives and pharmaceutical compositions containing the same
IS6385A (is) Ný notkun og nýjar N-asabísýkló-amíð afleiður
DK1417175T3 (da) Substituerede dihydro-3-halo-1h-pyrazol-5-carboxylater og fremstillingog anvendelse heraf
IL155196A0 (en) Benzamide derivatives and pharmaceutical compositions containing the same
IL158300A0 (en) Bisarylimidazol derivatives and pharmaceutical compositions containing the same
IL158044A0 (en) Cyclopropylindole derivatives and pharmaceutical compositions containing the same
NO20012567D0 (no) Azepinoindolderivater, fremstilling og anvendelse derav
IL156812A0 (en) Phthalazinone-piperidino derivatives and pharmaceutical compositions containing the same
NO20014490L (no) Medisinske blandinger
NO20034159D0 (no) Östrogen-gestagen-kombinasjonspreparat og anvendelse derav
EE05020B1 (et) Glburiidi ravimkoostis
IL157740A0 (en) Heterocyclic derivatives and pharmaceutical compositions containing the same
IS2841B (is) Samstæða hluta og lyfjasamsetningar
DK1057813T3 (da) Indolderivater og medicinske sammensætninger indeholdende de samme
IS7275A (is) Samsetning fyrir hollegg og notkun á henni
NO20030156D0 (no) Farmasöytiske sammensetninger og fremgangsmåter for anvendelse derav
IL159085A0 (en) Heterocyclic derivatives and pharmaceutical compositions containing the same
DK1263719T3 (da) N-deacetylthiocolchin-derivater og farmaceutiske sammensætninger indeholdende disse.
DE60117096D1 (de) Dihydroindol- und tetrahydrochinolinderivate